Kapur, A.; Mehta, P.; Simmons, A.D.; Ericksen, S.S.; Mehta, G.; Palecek, S.P.; Felder, M.; Stenerson, Z.; Nayak, A.; Dominguez, J.M.A.;
et al. Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers. Cancers 2022, 14, 2297.
https://doi.org/10.3390/cancers14092297
AMA Style
Kapur A, Mehta P, Simmons AD, Ericksen SS, Mehta G, Palecek SP, Felder M, Stenerson Z, Nayak A, Dominguez JMA,
et al. Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers. Cancers. 2022; 14(9):2297.
https://doi.org/10.3390/cancers14092297
Chicago/Turabian Style
Kapur, Arvinder, Pooja Mehta, Aaron D Simmons, Spencer S. Ericksen, Geeta Mehta, Sean P. Palecek, Mildred Felder, Zach Stenerson, Amruta Nayak, Jose Maria Ayuso Dominguez,
and et al. 2022. "Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers" Cancers 14, no. 9: 2297.
https://doi.org/10.3390/cancers14092297
APA Style
Kapur, A., Mehta, P., Simmons, A. D., Ericksen, S. S., Mehta, G., Palecek, S. P., Felder, M., Stenerson, Z., Nayak, A., Dominguez, J. M. A., Patankar, M., & Barroilhet, L. M.
(2022). Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers. Cancers, 14(9), 2297.
https://doi.org/10.3390/cancers14092297